Venomics: a new paradigm for natural products-based drug discovery
Irina Vetter(Centre National de la Recherche Scientifique), Glenn F. King(The University of Queensland), Mehdi Mobli(The University of Queensland), Raveendra Anangi(The University of Queensland), Jasmine L. Davis(The University of Queensland), Lachlan D. Rash(The University of Queensland), Paul F. Alewood(The University of Queensland), Richard J. Lewis(AstraZeneca (Netherlands))
Cited by 191
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422